‘Better decisions and shorter project timelines’: Optibrium taps InfoChem to up offering

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags: Drug discovery, Design, Software, Research, Preclinical contract research, Informatics

Optibrium develops software for drug discovery and today announces a collaboration with InfoChem GmbH, a cheminformatics company, to provide users with a computer-aided synthesis design tool.

According to the companies, the collaboration will provide users of StarDrop – Optibrium’s lead product – with access to ICSYNTH light, an entry-level version of InfoChem’s computer-aided synthesis design (CASD) software, which enables the generation of synthesis pathways for a target molecule.

Dr. Matthew Segall, Optibrium’s CEO told us the InfoChem’s deisgn tool will be a “valuable contribution to StarDrop’s comprehensive range of optional plug-in modules.”

Segall added, “StarDrop ensures that scientists can quickly understand structure-activity relationships, identify potential liabilities and design new compounds with the highest chance of success, leading to better decisions and shorter project timelines.”

Optibrium company works closely with a range of customers and collaborators, including global pharma, biotech, and academic groups, among others. Segall in a press release that the partnership with InfoChem “continues our collaborative approach to working with leading providers of technology and services for drug discovery and other chemistry fields."

“We have developed StarDrop to seamlessly connect with a wide range of informatics systems thus giving our customers ultimate choice and flexibility, and providing everything they need for effective compound design and optimization through a single interface,”​ he added.

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more